Management Team

Berno Maaswinkel

Chief Executive Officer
“Loosing sight affects almost everything in life. We would like to help.”
Read more

Carel Hoyng

Senior Clinical Scientist, Founder, Key opinion leader Retinal Disease
“My ultimate goal is to find a cure for inherited retinal diseases”
Read more

Rob Collin

Chief Scientific Officer, Founder, Inventor RNA Therapy
“Due to their high specificity, antisense oligonucleotides hold great promise to correct RNA defects underlying many inherited diseases”
Read more


Erwin van Wijk

Senior Scientist
"Being able to save vision will be a life-changing event for people with a blinding disorder"
Read more

Irene Vázquez Domínguez

Postdoctoral Researcher
"It is very important to reach new paths to make the distance between bench and bed shorter"
Read more

Tom Koemans

Clinical Research Associate
"I like to contribute to the development of these innovative RNA therapies and to treat and cure degenerative diseases of the retina. By this, I hope to improve health care worldwide. "
Read more

Femke Bukkems

Research technician
"By researching treatment for retinal disorders, I hope to help and eventually cure patients with these diseases so that they can once again enjoy all that is happening around them."
Read more

General advisors

Markwin Velders

General Advisor

Dr. Markwin Velders obtained his PhD in molecular immunology at the Leiden University and worked as scientist and assistant professor at Loyola University Chicago, authoring over 40 peer reviewed papers.…

Read more

Maarten Scholten

General Advisor

After obtaining his law degree at the University of Amsterdam (The Netherlands), Mr. Scholten started his career as an attorney at the Amsterdam and New York offices of Loeff &…

Read more

Lucy Peltenburg

General Advisor

After obtaining her PhD in molecular biology of cancer at the University of Leiden, Dr. Lucy Peltenburg worked as a post-doc at the Biology department at the University of California…

Read more
Back To Top